IVCC
Company number 06719882 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
- Incorporated
- 2008-10-09
- Registered office
- Liverpool School Of Tropical Medicine, Pembroke Place, Liverpool, Merseyside, L3 5QA
- Postcode
- L3 5QA
- Accounts category
- Full
Accounts
- Last made up to
- 2025-07-31
- Next due by
- 2027-04-30
- Financial year end
- 31 July
Confirmation statement
- Last statement dated
- 2025-10-06
- Next due by
- 2026-10-20
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
- 72190 Other research and experimental development on natural sciences and engineering
Officers 10 current · 26 resigned
Registered charity
IVCC — charity number 1128437
Source: Charity Commission for England and Wales, Open Government Licence v3.0.
Modern slavery statement
Registered a modern slavery statement for 2025 (period to 2024-07-31) as part of the LIVERPOOL SCHOOL OF TROPICAL MEDICINE group statement — 2 years on the registry.
Read the statement summary on the government modern slavery statement registry. Contains public sector information licensed under the Open Government Licence v3.0.
Data protection registration
Registered with the ICO as a data protection fee payer — ZA591419 (Tier 1), registered since 2020.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- ivcc.com
- Phone
- 01517029323, +44 7712402498, +44 1517053268
IVCC works globally to facilitate innovative approaches to preventing vector-borne diseases and tackle the growing threat of insecticide resistance.
Among its peers
2nd oldest
of 23 similar companies in L, trading since 2008
The class of 2008
24%
of the 245,266 companies incorporated in 2008 are still active today; 74% have since been dissolved.
A fact about the year, not a forecast for this company.